As small molecule APIs become increasingly complex, longer synthetic pathways present new challenges for process chemists. Drug developers are turning to evolving tools to find reliable and efficient synthesis routes to produce small molecule APIs. This white paper outlines the advanced retrosynthetic analysis services offered by Lonza’s Small Molecules division and how these tools empower better, more efficient development of innovative small molecule drugs.
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy